SEC
SlamSEC
SearchBrowseEarnings

NYMOX PHARMACEUTICAL CORP

OTC:NYMXF
In Vitro & In Vivo Diagnostic Substances·QUEBEC CANADA, A8
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

All Filings(401 total)

TypeDateAccessionPeriodSize
6-K
Nov 7, 2025
0001640334-25-001988FORM 6-K
Nov 7, 2025
9.7 KB
6-K
Oct 22, 2025
0001640334-25-001864FORM 6-K
Oct 22, 2025
8.9 KB
6-K
Oct 22, 2025
0001640334-25-001862FORM 6-K
Oct 22, 2025
9.7 KB
6-K
Sep 23, 2025
0001640334-25-001701FORM 6-K
Sep 23, 2025
12.7 KB
20-F
Jun 3, 2025
0001640334-25-000972FORM 20-F
Dec 31, 2024
5.7 MB
6-K
May 22, 2025
0001640334-25-000923FORM 6-K
May 22, 2025
9.3 KB
NT 20-F
May 1, 2025
0001640334-25-000728FORM 20-F
Dec 31, 2024
41.6 KB
6-K
Mar 11, 2025
0001640334-25-000362FORM 6-K
Mar 11, 2025
32.0 KB
6-K
Jan 2, 2025
0001640334-25-000006FORM 6-K
Sep 30, 2024
2.2 MB
6-K
Dec 17, 2024
0001640334-24-001904FORM 6-K
Dec 17, 2024
30.2 KB
20-F
Aug 29, 2024
0001640334-24-001383FORM 20-F
Dec 31, 2023
5.7 MB
6-K
Jul 18, 2024
0001640334-24-001139FORM 6-K
Jul 18, 2024
32.7 KB
6-K
Jul 16, 2024
0001640334-24-001122FORM 6-K
Jul 17, 2024
39.7 KB
6-K
May 13, 2024
0001640334-24-000763FORM 6-K
May 13, 2024
19.9 KB
6-K
Mar 28, 2024
0001640334-24-000510FORM 6-K
Mar 28, 2024
711.7 KB
6-K
Nov 15, 2023
0001640334-23-002155FORM 6-K
Sep 30, 2023
2.2 MB
6-K
Nov 9, 2023
0001640334-23-002040FORM 6-K
Nov 9, 2023
30.1 KB
6-K
Nov 6, 2023
0001640334-23-002021FORM 6-K
Nov 3, 2023
136.1 KB
6-K
Oct 26, 2023
0001640334-23-001964FORM 6-K
Oct 26, 2023
27.6 KB
6-K
Sep 25, 2023
0001640334-23-001739FORM 6-K
Sep 25, 2023
25.1 KB
25-NSE
Sep 8, 2023
0001354457-23-000656
—
4.3 KB
6-K
Aug 29, 2023
0001640334-23-001653FORM 6-K
Aug 29, 2023
27.3 KB
6-K
Aug 14, 2023
0001640334-23-001575FORM 6-K
Jun 30, 2023
2.2 MB
6-K
Aug 2, 2023
0001640334-23-001425FORM 6-K
Aug 2, 2023
25.2 KB
6-K
Jul 31, 2023
0001640334-23-001389FORM 6-K
Jul 31, 2023
1.1 MB
25 filings shown